CONTACT US   |  (864) 397-5101

Nephron Pharmaceuticals adds four new hires to its C-suite


Nephron Pharmaceuticals in West Columbia has  recently hired four key executives.

Nola Grant has joined as chief human resources officer, Min Ha is the new chief of quality, Rene Herrera takes on the role of chief of process engineering and Monique Harvin has been selected as director of quality compliance. 

“The industry knowledge and experience between Min, Rene, Nola and Monique is unmatched,” said Nephron CEO and owner Lou Kennedy. “The excellence, work ethic and leadership of our team continues to make me proud. I am confident they are equipped with all the tools needed to take Nephron to the next level.” 

Grant has more than 18 years of HR experience. She is the former executive director of human resources at Charter Communications, where she had oversight of the largest call center in the nation.

She is a member of The Society of Human Resource Management and serves on the board of directors for United Way. Grant holds a master’s degree in human resources management from Webster University. 

Min Ha has more than 20 years of experience in commercial and clinical aseptic pharmaceutical manufacturing. Prior to Nephron, Ha worked as the director of clinical trial material and device quality at Avalyn Pharma providing quality and compliance oversight of pharmaceutical development manufacturing. He has served in senior leadership roles at SteadyMed Therapeutics, Mylan Global Respiratory Group and Mylan Specialty LP. Ha received his Bachelor of Science in microbiology from California Polytechnic State University.  

 Herrera has more than 29 years of pharmaceutical industry experience. Before taking the role of chief of process engineering, Herrera served as the director of facilities and engineering at August Bioservices, where he was responsible for all automation and engineering activities, as well as the execution of capital projects. He has also held leadership positions in engineering at Curia Global, Colgate and Glenmark Pharmaceuticals. Herrera earned his Master of Science in automatic control from Cinvestav. 

Prior to joining the Nephron team, Harvin served as the director of respiratory care at Providence Health South Carolina, where she received the LifePoint Health Mercy Award for her efforts and positive impact on hospital patients and the community. She has held adjunct instructor positions at Webster University and Midlands Technical College. Harvin holds a master’s in health care administration from South University. 

Based in West Columbia, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.